Posted on 27 May 2017

VIVEbiotech receives the Seal of Excellence granted by the European Commission

The European Commission has awarded VIVEbiotech the Seal of Excellence for the development of Lentisoma, an innovative safe vehicle for genes that serve as medicines.

This qualification falls within the Framework Program of the European Union for Research and Innovation 2014-2020 and aims to promote innovative SMEs in the field of health biotechnology.

This Seal of Excellence is an international recognition of the work done by the Basque company located to develop a high-quality project that contributes to the cure of monogenic diseases.